ESPE2023 Poster Category 1 Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology (56 abstracts)
1Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chula Memorial Hospital, Bangkok, Thailand. 2Center of Excellence in Transgender Health (CETH), Chulalongkorn University, Bangkok, Thailand
Background: Transgender youth in Thailand often encounter limitations when accessing gender services, leading many to use non-prescribed hormones. However, there is limited information available on the specific types of hormones used by this population.
Objectives: This study aimed to investigate the characteristics of transgender female youth in Thailand and the types of hormones they use.
Methods: From September 2021 to October 2022, a self-administered questionnaire was distributed via social media platforms including Facebook, LINE open chat, and Twitter.
Results: In this cross-sectional study, a total of 254 transgender female youth participated, of which 89% (n=226) reported previous hormone use. The mean age at first hormone use was 15.5 years (SD 2.5). Most of the hormone users (94.6%) reported disclosing their gender identity, while 60% of non-users had not disclosed to anyone. Among the hormone users, 35.8% reported using a single hormone, 37.5% reported using two hormones, and 26.7% reported using more than two hormones. The most commonly reported hormone used was oral cyproterone acetate (52.3%), followed by oral estradiol valerate (46.2%) and oral estradiol (38.3%). Additionally, 23.7% reported previous use of oral contraceptive pills, 7.5% used oral phytoestrogen, 3.8% used estrogen gel, and 2.2% used estrogen/estradiol injection or Hydroxyprogesterone caproate injection. The mean happiness score was similar between the ever-using hormone(s) group (7.0±1.9) and the never-using hormone(s) group (7.3±1.9).
Conclusion: This study demonstrated that Thai transgender female youth begin hormone use at an early age of approximately 15 years old and often use multiple types of hormones, with a significant proportion reporting previous use of contraceptive pills. These findings underscore the importance of promoting medical accessibility and providing appropriate hormone use supervision to ensure the safety and well-being of this population. Further research is needed to better understand the long-term effects of hormone use among transgender youth in Thailand.